SCHEMBL721825

SCHEMBL721825

CC(C)CCCCCCCCCc1ccc(C(=O)O)c(C(=O)O)c1CCCCCCCCCC(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 4/20 0.38
MCL1 Q07820 4/20 0.38
BCL2L1 Q07817 3/20 0.38
BAK1 Q16611 3/20 0.38
PPARA Q07869 3/20 0.38
KAT8 Q9H7Z6 2/20 0.38
PPARG P37231 1/20 0.38
EP300 Q09472 1/20 0.38
KAT2A Q92830 1/20 0.38
KAT2B Q92831 1/20 0.38
KAT5 Q92993 1/20 0.38
SAE1 Q9UBE0 1/20 0.38
RARB P10826 2/20 0.36
GRIN2D O15399 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
SLC16A3 O15427 2/20 0.35
HIF1A Q16665 1/20 0.35
EPAS1 Q99814 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29620154 1.00 BID (0.38) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL23670 1.00 BID (0.38) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL37016 1.00 BID (0.38) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL479330 1.00 BID (0.38) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL37130 1.00 BID (0.38) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL23222 1.00 BID (0.38) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL10818422 1.00 BID (0.38) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL541811 0.99 RARB (0.37) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL5180435 0.95 BID (0.43) BIDMCL1BCL2L1BAK1PPARA
SCHEMBL5516325 0.95 BID (0.43) BIDMCL1BCL2L1BAK1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373198-B2 STORAGE STABLE AQUEOUS ORGANIC PEROXIDE EMULSIONS AKZO NOBEL NV (NL) 2015-02-25 EP claimed
EP-1567470-B1 HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF EXXONMOBIL CHEM PATENTS INC (US) 2013-06-05 EP claimed
EP-2263709-A1 Medical device having hydration inhibitor Abbott Laboratories (US) 2010-12-22 EP claimed
US-7445792-B2 Medical device having a hydration inhibitor ABBOTT LABORATORIES (US) 2008-11-04 US claimed
EP-1373198-B1 STORAGE STABLE AQUEOUS ORGANIC PEROXIDE EMULSIONS AKZO NOBEL NV (NL) 2008-04-23 EP claimed
US-20060171984-A1 Device having hydration inhibitor ABBOTT LABORATORIES 2006-08-03 US claimed
EP-1536850-A1 MEDICAL DEVICE HAVING HYDRATION INHIBITOR Abbott Laboratories (US) 2005-06-08 EP claimed
US-20040180039-A1 Medical device having a hydration inhibitor ABBOTT LABORATORIES 2004-09-16 US claimed
WO-2004022124-A1 MEDICAL DEVICE HAVING HYDRATION INHIBITOR ABBOTT LABORATORIES (US) 2004-03-18 WO claimed
EP-0074112-B2 THERMOPLASTIC COMPOSITION Sumitomo Naugatuck Co., Ltd. (JP) 1993-06-23 EP claimed
EP-2682138-B2 Improved pharmaceutical-coated medical products, the production thereof and the use thereof INVATEC TECH CENTER GMBH (CH) 2025-06-11 EP disclosed
CN-117677684-A Crosslinkable silyl-terminated polymer composition and method of joining substrates using the same 博斯蒂克股份公司 2024-03-08 CN disclosed
CN-117616098-A Novel crosslinkable compositions with silyl-terminated polymers and corresponding self-adhesive articles 博斯蒂克股份公司 2024-02-27 CN disclosed
CN-116285878-A Thermally crosslinkable adhesive composition for forming a thermally stable adhesive seal 博斯蒂克股份公司 2023-06-23 CN disclosed
CN-116209717-A Adhesive composition for producing waterproof breathable articles 博斯蒂克股份公司 2023-06-02 CN disclosed
EP-0197728-B2 Preparation of thermoformed plastics articles GE CHEMICALS INC (US) 1999-03-03 EP disclosed
EP-0197728-B1 PREPARATION OF THERMOFORMED PLASTICS ARTICLES GE CHEMICALS, INC. (US) 1990-10-31 EP disclosed
US-4824907-A Preparation of thermoformed plastics articles BORG-WARNER CHEMICALS, INC. (US) 1989-04-25 US disclosed
EP-0197728-A2 Preparation of thermoformed plastics articles GE CHEMICALS, INC. (US) 1986-10-15 EP disclosed
US-4113635-A MONO-, DI-, OR TRI-PARTIAL ESTERS OF PENTAERYTHRITOL AND FATTY ACIDS NIPPON STEEL CORPORATION (JP) 1978-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180039-A1 Medical device having a hydration inhibitor AQP1, WFS1, MME BID 2157/4885MCL1 3636/4885BCL2L1 3711/4885
US-20060171984-A1 Device having hydration inhibitor SERPINB1, TTPA, LIPG BID 461/4885MCL1 209/4885BCL2L1 1550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.